Home » Medtronic’s Aortic Valve Earns Expanded CE Mark
Medtronic’s Aortic Valve Earns Expanded CE Mark
Medtronic has received an expanded CE mark certification for its Evolut transcatheter aortic valve implantation (TAVI) system.
The device, which is used to replace a diseased aortic valve, is now cleared in Europe for patients with severe native aortic stenosis who are considered at low risk of mortality during the surgery.
The device was previously approved for treatment of patients at intermediate, high and extremely high risk of surgical mortality.
Upcoming Events
-
07May
-
14May
-
30May